(Total Views: 187)
Posted On: 04/16/2024 12:45:01 PM
Post# of 108053

$NBIO - This announcement comes as the Company prepares for a Phase II trial that follows a very successful Phase I trial-where safety at five ascending dose cohorts was observed-involving 15 patients who received PTB for various types of brain tumors.
https://finance.yahoo.com/news/nascent-prepar...00620.html
https://finance.yahoo.com/news/nascent-prepar...00620.html

